Control of intestinal inflammation by interleukin-10.

@article{Kole2014ControlOI,
  title={Control of intestinal inflammation by interleukin-10.},
  author={Abhisake Kole and Kevin J. Maloy},
  journal={Current topics in microbiology and immunology},
  year={2014},
  volume={380},
  pages={
          19-38
        }
}
Twenty years ago, the observation that mice genetically deficient in IL-10 spontaneously developed severe intestinal inflammation, revealed an essential role for IL-10 in the maintenance of intestinal homeostasis. In the intervening period much has been learned about the cellular and molecular factors that are involved in IL-10-mediated regulatory pathways. Elegant experiments with conditional cell-type specific knockout strains have illustrated that IL-10 acts on both myeloid cells and T cells… 
TH17 cells express ST2 and are controlled by the alarmin IL-33 in the small intestine
TLDR
It is shown that TH17 cells accumulating in the small intestine upon inflammation express the IL-33 receptor (ST2) and intestinal epithelial cells (IEC) are the main source of the alarmin interleukin-33 (IL-33), and that pro-inflammatory TH17 Cells acquire a regulatory phenotype with immunosuppressive properties in response to IL- 33.
Transient activation of mucosal effector immune responses by resident intestinal bacteria in normal hosts is regulated by interleukin‐10 signalling
TLDR
Findings show that a resident E. coli that induces chronic colitis in monoassociated IL‐10‐deficient mice rapidly but transiently activates the effector immune system in normal hosts, in parallel with induction of protective IL-10 produced by B cells and CD4+ cells that subsequently suppresses this response to mediate mucosal homeostasis.
Epigenetic regulation of T helper cells and intestinal pathogenicity
TLDR
Considering the fundamental role of epigenetic regulation in immune cells, epigenetic mechanisms, particularly in T helper (Th) cells, may play a major role in the complex regulation of mucosal immunity.
Toll-like receptors 2 and 4 modulate intestinal IL-10 differently in ileum and colon
TLDR
Intestinal epithelial cells could release IL-10 in response to TLR activation, playing an intestinal tissue-dependent and critical intestinal immune role.
The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis
TLDR
Interleukin-10 (IL-10) is clearly a gatekeeper of fibrotic/antifibrotic signaling and its interaction with effector cells, particularly immune cells, will be critical to future studies in the field.
Experimental colitis in IL‐10‐deficient mice ameliorates in the absence of PTPN22
TLDR
Results show that PTPN22 promotes intestinal inflammation in IL‐10‐deficient mice, suggesting that therapeutic targeting of PTPn22 might be beneficial in patients with IBD and mutations inIL‐10 and IL‐ 10R.
Macrophage-derived IL-10 mediates mucosal repair by epithelial WISP-1 signaling.
TLDR
The involvement of macrophages in regulating an IL-10/CREB/WISP-1 signaling axis is defined, with broad implications in linking innate immune activation to mucosal wound repair.
Protein tyrosine phosphatase SAP-1 protects against colitis through regulation of CEACAM20 in the intestinal epithelium
TLDR
It is shown that SAP-1 ablation in interleukin (IL)-10–deficient mice, a model of inflammatory bowel disease, resulted in a marked increase in the severity of colitis in association with up-regulation of mRNAs for various cytokines and chemokines in the colon.
...
...

References

SHOWING 1-10 OF 124 REFERENCES
Helicobacter hepaticus-Induced Colitis in Interleukin-10-Deficient Mice: Cytokine Requirements for the Induction and Maintenance of Intestinal Inflammation
TLDR
A crucial role is demonstrated for IL-12 in both inducing and sustaining intestinal inflammation through recruitment and maintenance of a pool of pathogenic Th1 cells in mice reconstituted with H. hepaticus-induced colitis.
Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells
An Essential Role for Interleukin 10 in the Function of Regulatory T Cells That Inhibit Intestinal Inflammation
TLDR
It is shown that interleukin (IL)-10 is an essential mediator of the regulatory functions of the CD45RBlow population, providing the first clear evidence that IL-10 plays a nonredundant role in the functioning of regulatory T cells that control inflammatory responses towards intestinal antigens.
IL-23 plays a key role in Helicobacter hepaticus–induced T cell–dependent colitis
TLDR
The data demonstrate that IL-23 and not IL-12 is essential for the development of maximal intestinal disease, and support a model in which IL- 23 drives both interferon γ and IL-17 responses that together synergize to trigger severe intestinal inflammation.
Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.
We have characterized the progressive stages of chronic intestinal inflammation that develops spontaneously in specific pathogen-free (SPF) mice with a targeted disruption in the IL-10 gene
MyD88 signalling in colonic mononuclear phagocytes drives colitis in IL-10 deficient mice
TLDR
Gut bacterial sensing through MyD88 in MNPs drives inflammatory bowel disease (IBD) when unopposed by IL-10.
Innate lymphoid cells drive IL-23 dependent innate intestinal pathology
TLDR
It is shown that bacteria-driven innate colitis is associated with an increased production of IL-17 and interferon-γ in the colon, and IL-23-responsive innate intestinal cells are identified, which may represent a target in inflammatory bowel disease.
Interleukin-10-deficient mice develop chronic enterocolitis
A Protective Role for Human IL-10–Expressing CD4+ T Cells in Colitis
TLDR
Experimental evidence verifying the importance of T cell-derived hIL-10 expression in controlling inflammation within the colonic mucosa is provided and molecular evidence suggesting the tissue microenvironment influences IL-10expression patterns and chromatin structure in the human (and mouse) IL10 locus is provided.
...
...